Privacy preferences
Inderes uses cookies to provide a better user experience and a personalised service. By consenting to the use of cookies, we can develop an even better service and will be able to provide content that is interesting to you.
  • Forum
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Earnings SeasonCompare EPS estimates to reported results
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Nightingale Health

0.90 EUR-0.88 %4.9, 17.29
4,760 following

HEALTH

NASDAQ Helsinki

Medical Equipment & Services

Health Care

Overview
Financials & Estimates
Investor views
Compare
-0.88 %
+5.65 %
+0.22 %
-37.98 %
-56.20 %
-59.27 %
-3.54 %
-81.78 %
-82.56 %

Nightingale Health operates in the medical technology sector. The company specializes in the development of medical technology products. The product portfolio is broad and includes platforms and services within blood analysis that are used for disease prevention purposes. In addition to the main business, service and related ancillary services are also offered. The business is operated globally with the largest presence in Europe.

Read more
Market cap
54.72M EUR
Turnover
40.92K EUR
P/E (adj.) (26e)
-3.13
EV/EBIT (adj.) (26e)
-0.83
P/B (26e)
1.06
EV/S (26e)
2.49
Dividend yield-% (26e)
-
Coverage
Recommendation
Buy
Target price
1.40 EUR
Updated
11.06.2026
Disclaimer
Antti Luiro
Antti Siltanen
Antti Siltanen, Antti Luiro
Show more
Latest research

Latest analysis report

Released: 12.06.2026

Latest extensive report

Released: 13.06.2025

Revenue and EBIT-%
EPS and dividend
Financial calendar
Risk
Business risk
Valuation risk
Low
High
All
Research
Webcasts
Press releases
ShowingAll content types

Forum discussions
Well, look at that. Quite a few entities see the benefits in this test, since they’ve adopted it. And even though a large portion of people don’t care about their own health, there are those who want as much measurable data about it as possible, and who also change their behavior...
9/1/2026, 7:43 PM
by Maikki
6
[quote="Pertti2, post:2813, topic:14314"]\nWelltus/Nightingale Japan\n[/quote]\nThe link you posted is likely at least four years old, from the time when they were targeting consumers directly in Japan. Now they are taking a fresh start, with the launch of the MyNightingale+ test...
9/1/2026, 8:20 AM
by Puutaheinää
2
Could Nightingale benefit from Terveystalo’s acquisition of Solo Health?
17 hours ago
by Tuuukka
1
It probably matters how these are brought to the market. It’s a bit like Oura, how much do those metrics actually help?
yesterday
by Matsku
1
I’m not saying that would necessarily actually happen, but the answer to your question is, in itself, obvious: diet and exercise.
yesterday
by KuinVain
1
Tell me, how do you adjust your usage according to the fatty acid balance? Or the inflammation score? The concept of health might now be expanding just a little bit beyond traditional Western school medicine. There are many entities, and the Japanese conception of health can differ...
9/2/2026, 3:13 AM
1
By reading the text, you can see that the blood test is taken in connection with a normal health check-up, not intended “directly for consumers”, nor taken by the person themselves.
9/1/2026, 8:44 AM
by Pertti
1
Read more on our forum
Revenue and EBIT-%

Revenue M

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Financial calendar
16.9
2026

Annual report '26

5.11
2026

General meeting '26

9.3
2027

Interim report Q2'27

Nightingale Health 2025–2026 Results Webcast
Webcast16.09.2026, 13.00

Nightingale Health 2025–2026 Results Webcast

Nightingale Health
Regulatory press release19.08.2026, 08.00

Changes in Nightingale Health Plc's management team

Nightingale Health
Press release19.08.2026, 08.00

US healthcare commercial leader Hugh Watson joins Nightingale Health as Chief Commercial Officer, Americas

Nightingale Health

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Analyst Comment19.08.2026, 09.12 by
Antti Siltanen

Nightingale's remote tests to be included in Supernormal's weight loss service

The Supernormal collaboration, with over 10,000 users, integrates remote testing into GLP-1 medication treatments.

Nightingale Health
Press release18.08.2026, 08.57

Nightingale Health and Supernormal partner to bring at-home blood testing to medical weight loss in Finland

Nightingale Health
New partnership for Nightingale in the UK
Analyst Comment18.08.2026, 09.18 by
Antti Siltanen

New partnership for Nightingale in the UK

The partnership paves the way in the UK private healthcare market.

Nightingale Health
Press release17.08.2026, 10.30

Nightingale Health and Personalised Health Clinics collaborate on preventive metabolic health in the UK

Nightingale Health
Press release01.07.2026, 15.00

Nightingale Health and Archipelago Health partner to bring preventive screening to small-island health systems in the Crown Dependencies, Bermuda and the Caribbean

Nightingale Health
Regulatory press release29.06.2026, 17.15

Nightingale Health’s Board of Directors resolved on new stock option program

Nightingale Health
Nightingale: We factored the project delay into our estimates
Research12.06.2026, 09.20 by
Antti Siltanen, Antti Luiro

Nightingale: We factored the project delay into our estimates

The revenue outlook for the next fiscal year exceeds 10 MEUR.

Nightingale Health
Nightingale's profit warning: Project delay shifts revenue to next year
Analyst Comment09.06.2026, 08.40 by
Antti Siltanen

Nightingale's profit warning: Project delay shifts revenue to next year

The company's business appears to be progressing in line with our estimates.

Nightingale Health
Regulatory press release08.06.2026, 18.25

Inside information, profit warning: Nightingale Health continues to grow but will not reach its 50% growth target this financial year as about EUR 2 million of revenue shifts to next financial year

Nightingale Health
Nightingale: Nightingale sings to a deaf market
Research04.06.2026, 08.36 by
Antti Siltanen

Nightingale: Nightingale sings to a deaf market

The low valuation compensates for the very high level of risk.

Nightingale Health
Nightingale joins wellbeing services county research project
Analyst Comment29.05.2026, 08.46 by
Antti Siltanen

Nightingale joins wellbeing services county research project

Nightingale's risk screening selects participants for lifestyle coaching.

Nightingale Health
Press release28.05.2026, 10.00

Nightingale Health joins South Savo Wellbeing Services County's preventive healthcare research project in Finland

Nightingale Health
Regulatory press release27.05.2026, 15.45

Nightingale Health Plc’s financial reporting and Annual General Meeting in financial year 2026–2027

Nightingale Health
New partnership for Nightingale
Analyst Comment25.05.2026, 08.11 by
Antti Siltanen

New partnership for Nightingale

The new memorandum of understanding will expand blood analysis to the longevity programs in Switzerland and South Africa as early as this summer.

Nightingale Health
Press release22.05.2026, 08.30

Nightingale Health and Formula 100 Health partner in preventive health: Embedding multi-disease risk detection across longevity programmes in Switzerland and South Africa

Nightingale Health
Regulatory press release21.05.2026, 16.25

Nightingale Health Plc – Managers’ Transactions – Olli Karhi

Nightingale Health
Regulatory press release18.05.2026, 12.02

Nightingale Health Plc: Flagging notification in accordance with Chapter 9, Section 10 of the Securities Markets Act (Cor Group Oy)

Nightingale Health